Trial intelligence / Profile preview

Kangfu Gel for neurodermatitis and chronic eczema (wind-dryness pattern)

CTR20132908Phase 2Active

Sponsor
Beijing Incuris Biological Products Research Institute
Start
Jul 2014
Modality
Cytokines & Interferons → Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 2 trial of antiviral lozenge in neurodermatitis, atopic dermatitis (AD), sponsored by Beijing Incuris Biological Products Research Institute. Started Jul 2014; status: active.

02

Drugs

antiviral lozenge
03

Conditions

neurodermatitisatopic dermatitis (AD)

Beyond the preview

Go deeper on CTR20132908.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20132908.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call